Market research

PSYB.V PsyBio Therapeutics Corp

V CAD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 1M
P/E ratio: Not available
Analyst target: 2
Dividend yield: Not available
Beta: 0.66

Loading price history…

Profile

Company facts

Exchange: V
Currency: CAD
Sector: Healthcare
Industry: Biotechnology
ISIN: Not available
Market cap: 1M
P/E ratio: Not available
Analyst target: 2
Dividend yield: Not available
Beta: 0.66

About

About PsyBio Therapeutics Corp

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as Leo Acquisitions Corp. and changed its name to PsyBio Therapeutics Corp. in January 2021. The company is headquartered in Denver, Colorado.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about PSYB.V.

PSYB.V PsyBio Therapeutics Corp

Price & volume

Company facts

About PsyBio Therapeutics Corp

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet